Autoimmune Hemolytic Anemia After mRNA COVID Vaccine.

Fatima, Zainab; Reece, Blair R A; Moore, J Suzanne; Means, Robert T

Fatima, Zainab; Reece, Blair R A; Moore, J Suzanne; Means, Robert T.

Fatima Z; East Tennessee State University, Johnson City, USA.
Reece BRA; East Tennessee State University, Johnson City, USA.
Moore JS; East Tennessee State University, Johnson City, USA.
Means RT; East Tennessee State University, Johnson City, USA.

J Investig Med High Impact Case Rep ; 10: 23247096211073258, 2022.

Article in English | MEDLINE | ID: covidwho-1632182

ABSTRACT

ABSTRACT

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.

Subject(s)

Anemia, Hemolytic, Autoimmune; COVID-19; Vaccines; Anemia, Hemolytic, Autoimmune/chemically induced; COVID-19 Vaccines; Humans; RNA, Messenger/genetics; SARS-CoV-2

Keywords

COVID; COVID vaccine; autoimmune hemolytic anemia; hematology oncology; hemolysis; rheumatology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Anemia, Hemolytic, Autoimmune Type of study: Case report Topics: Vaccines Limits: Humans Language: English Journal: J Investig Med High Impact Case Rep Year: 2022 Document Type: Article Affiliation country: 23247096211073258

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google